Qlosr fortsätter leverera stigande prenumerationsintäkter under kvartalet.
Redeye retains its positive view of Efecte following a solid Q3 report, where the low churn, just li...
Redeye comments on 2cureX’s Q3’22 report. The company highlights positive results from an independen...
Redeye states that the Q3 report was a step in the right direction.
Redeye gives a short comment on today’s news of financial targets for the group.
First Venture publicerade den 24 november 2022 bolagets delårsrapport för tredje kvartalet år 2022.
Redeye comments on Fluoguide’s Q3 2022 report at a time when the company is approaching multiple cri...
Redeye comments on Lipigon's third quarter report, in particular on the SAD and recently initiated M...
Redeye comments on aXichem’s Q3 2022 report. The report did not include any surprises where sales ca...
Challenging year outweighed by record large order in ’23 Could play a role in further market consoli...
Redeye comments on CI Games Q3'22 report, which showed weaker profitability in the quarter.
Redeye positively views Hexatronic’s acquisition of KNET, which will provide micro duct for the west...
Redeye provides a first comment on the back of Northbaze Group’s Q3 report.
Redeye comments on Beyond Frames Q23’22 report, where net sales came in below expectations.
Redeye initiates coverage of Nepa, a scalable and rapidly growing software company in consumer scien...
Redeye initiates coverage of Xavi Solutions, a specialised Swedish IT consulting company set to grow...
‘23e-‘24e EBITA estimates up 5% Working capital build-up sets high Q4 expectations Share trading at ...
Redeye sees that Kontigo Care’s Q3 report came in close to our estimates, showing top-line growth of...
Q3 ARR ~2% lower vs. ABGSCe, adj. EBITDA better Reiterated guidance requires strong ARR growth in Q...
Acquires two companies, adding SEK 78m in sales ‘23e sales up ~6% and EBITA up 4% Demand within indu...
